Genmab A/S
Close on Nov 18, 2026
Genmab A/S Total Revenue by Collaboration Partner & Product Channel
Total Revenue by Collaboration Partner & Product Channel ($M)
Genmab A/S Total Revenue by Collaboration Partner & Product Channel: $1,038M in Q3 2026, up 13.1% from a year earlier. That is the highest of the 11 quarters on record here.
Where the Q3 2026 figure comes from
“|| Total* | $ | 1,038 | $ | 918 | $ | 2,828 | $ | 2,382”
Source: Genmab Form 6-K — Q3 2026 Interim Report (Nine Months Ended Sep 30, 2026) ↗
Consolidated revenue disaggregated by collaboration counterparty plus direct net product sales (Note 2.1 / Note 3).
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up total Revenue by Collaboration Partner & Product Channel
- J&J / Janssen Collaboration & Royalty Revenue794 · Q3 2026
- Novartis Collaboration & Royalty Revenue149 · Q3 2026
- Roche Collaboration & Royalty Revenue36 · Q3 2026
- Pfizer Collaboration Profit-Share & Milestone Revenue20 · Q3 2026
- AbbVie Collaboration Royalty, Milestone & Reimbursement Revenue (Annual)–
- BioNTech R&D Reimbursement Revenue2 · Q3 2026
- Direct Net Product Sales & Other Collaboration Counterparties27 · Q3 2026
Cite this data
StockData. (2026). Genmab A/S Total Revenue by Collaboration Partner & Product Channel ($M), quarterly Q1 2024–Q3 2026 [Data set]. Compiled from Genmab A/S SEC filings and investor materials. https://stockdatahq.com/stocks/gmab/kpis/partner-total
See every metric in the Genmab A/S KPI table. Data updated Nov 11, 2026.
See a number that looks wrong?